Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(4-methylaminobutoxy)diphenylmethane
2. 4-(2-benzylphenoxy)-n-methylbutylamine
3. Bifemelane
4. Celeport
5. Mci 2016
6. Mci-2016
1. 62232-46-6
2. Bifemelane Hcl
3. Bifemelane (hydrochloride)
4. 4-(2-benzylphenoxy)-n-methylbutan-1-amine Hydrochloride
5. Celeport
6. Alnert
7. Mci-2016
8. E-0687
9. N-methyl-4-(2-(phenylmethyl)phenoxy)-1-butanamine Hydrochloride
10. N-methyl-4-[2-(phenylmethyl)phenoxy]-1-butanamine Hydrochloride
11. 4-(o-benzylphenoxy)-n-methylbutylamine Hydrochloride
12. 2n52s01ufy
13. 2-benzyl-1-(4-(methylamino)butoxy)benzene Hydrochloride
14. Smr000449269
15. Cpd000449269
16. Mls000758314
17. Mls001423949
18. Schembl418851
19. Chembl543763
20. Hy-b1558a
21. Dtxsid40977808
22. Son-216
23. Regid_for_cid_6917789
24. Bfm-2703
25. Bifemelane Hydrochloride [mi]
26. Akos024458638
27. Ccg-100791
28. Nc00041
29. Bifemelane Hydrochloride [who-dd]
30. Bs-48829
31. B6442
32. Cs-0020979
33. Ec-000.2091
34. E75763
35. 4-(2-benzylphenoxy)-n-methylbutylamine Hydrochloride
36. Q27255055
37. 4-(2-benzylphenoxy)-n-methylbutan-1-amine;hydrochloride
38. 4-(2-benzylphenoxy)-n-methylbutan-1-aminehydrochloride
39. 4-(2-benzylphenoxy)-n-methylbutan-1-amine--hydrogen Chloride (1/1)
| Molecular Weight | 305.8 g/mol |
|---|---|
| Molecular Formula | C18H24ClNO |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 8 |
| Exact Mass | 305.1546421 g/mol |
| Monoisotopic Mass | 305.1546421 g/mol |
| Topological Polar Surface Area | 21.3 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 238 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
ABOUT THIS PAGE
38
PharmaCompass offers a list of Bifemelane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bifemelane manufacturer or Bifemelane supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bifemelane manufacturer or Bifemelane supplier.
PharmaCompass also assists you with knowing the Bifemelane API Price utilized in the formulation of products. Bifemelane API Price is not always fixed or binding as the Bifemelane Price is obtained through a variety of data sources. The Bifemelane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bifemelane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bifemelane, including repackagers and relabelers. The FDA regulates Bifemelane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bifemelane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bifemelane supplier is an individual or a company that provides Bifemelane active pharmaceutical ingredient (API) or Bifemelane finished formulations upon request. The Bifemelane suppliers may include Bifemelane API manufacturers, exporters, distributors and traders.
Bifemelane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bifemelane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bifemelane GMP manufacturer or Bifemelane GMP API supplier for your needs.
A Bifemelane CoA (Certificate of Analysis) is a formal document that attests to Bifemelane's compliance with Bifemelane specifications and serves as a tool for batch-level quality control.
Bifemelane CoA mostly includes findings from lab analyses of a specific batch. For each Bifemelane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bifemelane may be tested according to a variety of international standards, such as European Pharmacopoeia (Bifemelane EP), Bifemelane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bifemelane USP).
